J Refract Surg. 2021 Dec;37(12):800-808. doi: 10.3928/1081597X-20210812-03. Epub 2021 Dec 1.
To report the incidence of ectasia after small incision lenticule extraction (SMILE) in a high-volume refractive surgery center in India.
To derive the incidence of ectasia after SMILE, all eyes that underwent SMILE or SMILE Xtra (SMILE combined with prophylactic accelerated corneal cross-linking) from November 2012 to August 2019 were retrospectively analyzed. Furthermore, these cases were classified as being "normal" or "borderline" based on certain predefined criteria. Only eyes with a minimum follow-up of 12 months were included.
Of the total 7,024 eyes analyzed, 6,619 eyes underwent SMILE, of which 10 eyes developed ectasia at a mean interval of 21.3 months, making the incidence of ectasia after SMILE 0.15%. Of these 10 eyes with ectasia, 2 eyes had normal preoperative topography, whereas the remaining 8 eyes were borderline as per the predefined criteria. Retrospective data analysis revealed that 6,025 of 7,024 eyes were normal and thus suitable for a standard SMILE procedure, whereas 999 eyes were borderline, of which 594 eyes underwent SMILE and 405 eyes underwent SMILE Xtra. The incidence of ectasia in borderline eyes undergoing SMILE was 0.80% (8 of 999) versus 0% (none) for borderline eyes undergoing SMILE Xtra (chi square, < .05).
The incidence of ectasia after SMILE in the early postoperative period was 0.15%, with borderline eyes accounting for most cases. Borderline eyes treated with SMILE Xtra did not progress to ectasia, potentially suggesting a protective role of simultaneous CXL. .
报告在印度一家高容量屈光手术中心进行小切口透镜切除术(SMILE)后的扩张发生率。
为了得出 SMILE 后扩张的发生率,回顾性分析了 2012 年 11 月至 2019 年 8 月期间所有接受 SMILE 或 SMILE Xtra(SMILE 联合预防性加速角膜交联)的患者。此外,根据某些预先定义的标准,将这些病例分为“正常”或“临界”。仅纳入至少随访 12 个月的患者。
在分析的 7024 只眼中,有 6619 只眼接受了 SMILE,其中 10 只眼在平均 21.3 个月时出现扩张,SMILE 后扩张的发生率为 0.15%。这 10 只扩张眼中,有 2 只眼术前地形图正常,而其余 8 只眼根据预定标准为临界。回顾性数据分析显示,7024 只眼中有 6025 只眼正常,适合进行标准 SMILE 手术,而有 999 只眼为临界,其中 594 只眼接受了 SMILE,405 只眼接受了 SMILE Xtra。在接受 SMILE 的临界眼中,扩张的发生率为 0.80%(999 只眼中的 8 只),而在接受 SMILE Xtra 的临界眼中则为 0%(无一例)(卡方,<.05)。
SMILE 后早期扩张的发生率为 0.15%,以临界眼为主。接受 SMILE Xtra 治疗的临界眼未进展为扩张,这可能表明同时行 CXL 具有保护作用。